Free Trial

Vera Therapeutics (VERA) Short Interest Ratio & Short Volume

Vera Therapeutics logo
$48.46 +0.35 (+0.73%)
(As of 12/6/2024 ET)

Vera Therapeutics Short Interest Data

Vera Therapeutics (VERA) has a short interest of 6.55 million shares, representing 13.98% of the float (the number of shares available for trading by the public). This marks a 2.50% increase in short interest from the previous month. The short interest ratio (days to cover) is 8.7, indicating that it would take 8.7 days of the average trading volume of 886,029 shares to cover all short positions.

Current Short Interest
6,550,000 shares
Previous Short Interest
6,390,000 shares
Change Vs. Previous Month
+2.50%
Dollar Volume Sold Short
$303.00 million
Short Interest Ratio
8.7 Days to Cover
Last Record Date
November 15, 2024
Outstanding Shares
63,323,000 shares
Float Size
46,840,000 shares
Short Percent of Float
13.98%
Today's Trading Volume
315,343 shares
Average Trading Volume
886,029 shares
Today's Volume Vs. Average
36%
Short Selling Vera Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Vera Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

VERA Short Interest Over Time

VERA Days to Cover Over Time

VERA Percentage of Float Shorted Over Time

Vera Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/15/20246,550,000 shares $303.00 million +2.5%14.0%8.7 $46.26
10/31/20246,390,000 shares $258.03 million +3.2%13.3%9 $40.38
10/15/20246,190,000 shares $248.90 million +0.3%14.9%11.7 $40.21
9/30/20246,170,000 shares $272.71 million -4.5%14.9%11.3 $44.20
9/15/20246,460,000 shares $242.31 million +6.8%15.6%11.6 $37.51
8/31/20246,050,000 shares $228.81 million -0.5%14.6%11.3 $37.82
8/15/20246,080,000 shares $226.42 million -0.2%14.7%9.9 $37.24
7/31/20246,090,000 shares $222.83 million +1.7%14.7%9.4 $36.59
7/15/20245,990,000 shares $220.13 million -2.1%14.4%8.2 $36.75
6/30/20246,120,000 shares $221.42 million -0.1%14.7%6.9 $36.18
6/15/20246,123,800 shares $220.58 million +0.9%14.7%6.7 $36.02
5/31/20246,070,000 shares $230.60 million -6.0%14.5%6.6 $37.99
5/15/20246,460,000 shares $275.78 million -5.0%15.5%6.7 $42.69
4/30/20246,800,000 shares $268.67 million +7.8%16.6%6.5 $39.51
4/15/20246,310,000 shares $293.60 million -0.3%16.1%4.5 $46.53
3/31/20246,330,000 shares $272.95 million +1.4%16.1%4.9 $43.12
3/15/20246,240,000 shares $269.88 million +0.7%16.2%5.1 $43.25
2/29/20246,200,000 shares $291.90 million -8.4%16.5%5.3 $47.08
2/15/20246,770,000 shares $308.10 million +2.4%19.6%6.3 $45.51
1/31/20246,610,000 shares $240.74 million +9.3%19.1%6.6 $36.42
1/15/20246,050,000 shares $114.65 million -3.7%21.5%10.3 $18.95
12/31/20236,280,000 shares $96.59 million +11.2%22.2%11.3 $15.38
12/15/20235,650,000 shares $90.40 million +5.6%20.0%10.7 $16.00
11/30/20235,350,000 shares $72.49 million +6.6%19.0%9.3 $13.55
11/15/20235,020,000 shares $67.07 million +1.2%17.8%8.5 $13.36
10/31/20234,960,000 shares $51.68 million -9.3%17.8%8.8 $10.42
10/15/20235,470,000 shares $58.20 million +11.9%19.9%10.7 $10.64
9/30/20234,890,000 shares $67.04 million +32.9%17.8%10.3 $13.71
9/15/20233,680,000 shares $62.89 million -2.9%13.4%7.3 $17.09
8/31/20233,790,000 shares $67.05 million +15.9%13.8%5.4 $17.69
8/15/20233,270,000 shares $57.85 million +6.2%11.9%4.7 $17.69
7/31/20233,080,000 shares $57.81 million -8.3%11.1%4.5 $18.77
7/15/20233,360,000 shares $56.92 million -2.6%12.3%5 $16.94
6/30/20233,450,000 shares $55.37 million -3.1%12.7%5.1 $16.05
6/15/20233,560,000 shares $45.28 million +24.5%13.4%5.6 $12.72
5/31/20232,860,000 shares $23.88 million -5.0%10.8%7.3 $8.35
5/15/20233,010,000 shares $23.99 million -9.1%11.3%7.5 $7.97
4/30/20233,310,000 shares $22.01 million +30.3%14.2%7.1 $6.65
4/15/20232,540,000 shares $15.93 million -28.9%9.7%4.6 $6.27
3/31/20233,570,000 shares $27.70 million +32.7%14.2%5.4 $7.76
Elon Musk’s chilling warning for humanity (Ad)

The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.

3/15/20232,690,000 shares $19.18 million +15.5%10.7%3.2 $7.13
2/28/20232,330,000 shares $17.31 million +3.6%9.1%3 $7.43
2/15/20232,250,000 shares $17.71 million +47.1%8.8%3.1 $7.87
1/31/20231,530,000 shares $12.97 million +23.4%7.6%2.3 $8.48
1/15/20231,240,000 shares $8.36 million -12.1%9.3%2.4 $6.74
12/30/20221,410,000 shares $27.28 million -7.2%10.6%3.4 $19.35
12/15/20221,520,000 shares $29.14 million -22.1%11.4%11.7 $19.17
11/30/20221,950,000 shares $32.57 million -4.9%14.7%16 $16.70
11/15/20222,050,000 shares $34.54 million +15.8%15.5%18.9 $16.85
10/31/20221,770,000 shares $32.99 million +10.6%14.7%18.1 $18.64
10/15/20221,600,000 shares $30.69 million -1.2%13.3%18.6 $19.18
9/30/20221,620,000 shares $34.52 million +14.9%13.4%18.8 $21.31
9/15/20221,410,000 shares $30.13 million -10.2%11.7%16.2 $21.37
8/31/20221,570,000 shares $34.12 million +4.0%13.2%18 $21.73
8/15/20221,510,000 shares $32.69 million +14.4%12.6%18.9 $21.65
7/31/20221,320,000 shares $22.77 million +16.8%11.1%15 $17.25
7/15/20221,130,000 shares $18.14 million +20.1%9.5%12 $16.05
6/30/2022941,300 shares $12.81 million +28.2%7.9%10.2 $13.61
6/15/2022734,500 shares $10.28 million +83.6%6.2%8.2 $13.99
5/31/2022400,000 shares $5.82 million -12.5%3.3%4.1 $14.54
5/15/2022456,900 shares $6.99 million +8.1%3.8%4.7 $15.29
4/30/2022422,600 shares $8.45 million +41.2%3.4%3.6 $20.00
4/15/2022299,200 shares $6.92 million -46.3%2.4%2.7 $23.12
3/31/2022557,000 shares $13.08 million +40.1%4.5%5.3 $23.49
3/15/2022397,700 shares $9.55 million +39.1%3.1%3.6 $24.01
2/28/2022286,000 shares $6.64 million -16.7%2.2%2.8 $23.21
2/15/2022343,400 shares $6.81 million -4.3%3.7%3.5 $19.83
1/31/2022358,800 shares $7.15 million +27.9%4.9%5.2 $19.93
1/15/2022280,600 shares $5.61 million +15.6%3.8%4.6 $19.99
12/31/2021242,700 shares $6.48 million +185.2%3.3%4.2 $26.72
12/15/202185,100 shares $1.92 million +7.2%1.2%1.4 $22.51
11/30/202179,400 shares $2.84 million -36.6%1.1%1 $35.80
11/15/2021125,200 shares $2.93 million -32.4%1.7%1.6 $23.40
10/29/2021185,100 shares $3.58 million +43.8%2.5%2.6 $19.35
10/15/2021128,700 shares $1.93 million +15.8%1.7%1.8 $15.01
9/30/2021111,100 shares $1.93 million +376.8%1.5%1.7 $17.35
9/15/202123,300 shares $712,980.00 +651.6%0.3%0.4 $30.60
8/31/20213,100 shares $45,694.00 +24.0%0.0%0.1 $14.74
8/13/20212,500 shares $42,350.00 No Change0.0%0.1 $16.94

VERA Short Interest - Frequently Asked Questions

What is Vera Therapeutics' current short interest?

Short interest is the volume of Vera Therapeutics shares that have been sold short but have not yet been closed out or covered. As of November 15th, traders have sold 6,550,000 shares of VERA short. 13.98% of Vera Therapeutics' shares are currently sold short. Learn More on Vera Therapeutics' current short interest.

What is a good short interest ratio for Vera Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VERA shares currently have a short interest ratio of 9.0. Learn More on Vera Therapeutics's short interest ratio.

Which institutional investors are shorting Vera Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Vera Therapeutics: Jane Street Group LLC, and Belvedere Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Vera Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.98% of Vera Therapeutics' floating shares are currently sold short.

Is Vera Therapeutics' short interest increasing or decreasing?

Vera Therapeutics saw a increase in short interest in November. As of November 15th, there was short interest totaling 6,550,000 shares, an increase of 2.5% from the previous total of 6,390,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Vera Therapeutics' float size?

Vera Therapeutics currently has issued a total of 63,323,000 shares. Some of Vera Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vera Therapeutics currently has a public float of 46,840,000 shares.

How does Vera Therapeutics' short interest compare to its competitors?

13.98% of Vera Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Vera Therapeutics: Sarepta Therapeutics, Inc. (5.28%), Dr. Reddy's Laboratories Limited (1.39%), Vaxcyte, Inc. (7.77%), Catalent, Inc. (4.99%), Qiagen (1.61%), Roivant Sciences Ltd. (11.49%), Intra-Cellular Therapies, Inc. (1.72%), Revolution Medicines, Inc. (9.72%), Ascendis Pharma A/S (5.89%), Legend Biotech Co. (12.49%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($4.85 billion), Charter Communications, Inc. ($4.81 billion), International Paper ($2.96 billion), Cencora, Inc. ($2.40 billion), Paychex, Inc. ($2.38 billion), Lululemon Athletica Inc. ($2.05 billion), SoFi Technologies, Inc. ($2.03 billion), Live Nation Entertainment, Inc. ($1.93 billion), Onsemi ($1.82 billion), and Tractor Supply ($1.65 billion). View all of the most shorted stocks.

What does it mean to sell short Vera Therapeutics stock?

Short selling VERA is an investing strategy that aims to generate trading profit from Vera Therapeutics as its price is falling. VERA shares are trading up $0.35 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Vera Therapeutics?

A short squeeze for Vera Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VERA, which in turn drives the price of the stock up even further.

How often is Vera Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VERA, twice per month. The most recent reporting period available is November, 15 2024.




This page (NASDAQ:VERA) was last updated on 12/6/2024 by MarketBeat.com Staff
From Our Partners